Overview

Evaluation of the Effect of 10% Lidocaine Spray Undergoing Coronary Artery Bypass Graft Operation

Status:
Completed
Trial end date:
2017-09-20
Target enrollment:
0
Participant gender:
All
Summary
In patients undergoing coronary bypass surgery; 10% topical lidocaine administered endotracheally before intubation is to investigate the effect of hemodynamic response and EKG paramater after intubation.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Abant Izzet Baysal University
Treatments:
Lidocaine
Criteria
Inclusion Criteria:

- 50-75 between age patients

- ASA status III patients

- patients undergoing coronary artery bypass graft operation

Exclusion Criteria:

- cardiomyopathy,

- arrhythmia,

- valvular disease,

- electrolyte disorders

- chronic liver and kidney diseases

- use of medication that led to extended QT intervals